Tips on using this search form
- All search terms are case-insensitive
- If you specify more than one search option (e.g. you search for both "Authors" and "Paper title") then the publications returned will be those that match all of your search terms
- To reset the search form, click here
- Currently displaying 21 - 40 of 2403 publications
A Cathepsin B‐Triggered CO‐Releasing Molecule with a Non‐Toxic Metal Core for Targeted Tumor Delivery
Angewandte Chemie International Edition
(2025)
65
e13808
(doi: 10.1002/anie.202513808)
Identification of potent high-affinity secondary nucleation inhibitors of Aβ42 aggregation from an ultra-large chemical library using deep docking
Mol Syst Biol
(2025)
22
69
(doi: 10.1038/S44320-025-00159-5)
PhaseXplorer Creates High-Dimensional Phase Diagrams with Closed-Loop Active Learning.
ACS nano
(2025)
19
38981
(doi: 10.1021/acsnano.5c07268)
Neurodegeneration emerges at a cellular tipping point between aggregate accumulation and removal.
(2025)
(doi: 10.1101/2025.09.08.674880)
Droplet-based microfluidics uncovers hidden kinetic pathways of protein condensates: divergent routes to amyloids and amorphous aggregates.
(2025)
Kinetics of seeded protein aggregation: theory and application
(2025)
(doi: 10.48550/arxiv.2503.20941)
A Mathematical Model of Cellular Aggregation Predicts Patterns of Tau Accumulation in Neurodegenerative Disease
Adv Sci (Weinh)
(2025)
13
e11297
(doi: 10.1002/advs.202511297)
α-Synuclein driven cell susceptibility in Parkinson’s disease
(2025)
(doi: 10.21203/rs.3.rs-7375981/v1)
Tau catalyzes amyloid-β aggregation in a fold-dependent manner
(2025)
(doi: 10.1101/2025.10.21.683640)
YTHDC1 inhibition as a therapeutic strategy with potent preclinical activity alone and in combination with BCL-2 inhibitors
Molecular Cancer Therapeutics
(2025)
24
b124
Size of biomolecular condensates dictates fate in liquid–solid phase transitions through amorphous–amyloid competition
(2025)
(doi: 10.26434/chemrxiv-2025-6xwcg)
Serial amplification of tau filaments using Alzheimer's brain homogenates and C322A or C322S recombinant tau
FEBS Lett
(2025)
599
2768
(doi: 10.1002/1873-3468.70141)
Large-scale visualization of α-synuclein oligomers in Parkinson’s disease brain tissue
Nat Biomed Eng
(2025)
1
(doi: 10.1038/s41551-025-01496-4)
Nanoscale profiling of evolving intermolecular interactions in ageing FUS condensates
Communications chemistry
(2025)
8
284
(doi: 10.1038/s42004-025-01659-z)
Advances in Proximity-Assisted Bioconjugation.
Accounts of chemical research
(2025)
58
2939
(doi: 10.1021/acs.accounts.5c00368)
Optofluidic Waveguides for the Label-Free Study of Silk Protein Aggregates.
ACS Omega
(2025)
10
46115
(doi: 10.1021/acsomega.5c07826)
Secondary nucleation of α-Synuclein drives Mitochondria dysfunctions and Lewy body formation in Parkinson’s Disease
(2025)
(doi: 10.21203/rs.3.rs-7657706/v1)
Secondary nucleation of α-Synuclein drives Mitochondria dysfunctions and Lewy body formation in Parkinson’s Disease
(2025)
(doi: 10.1101/2025.09.17.676873)
Design of Tau Aggregation Inhibitors Using Iterative Machine Learning and a Polymorph-Specific Brain-Seeded Fibril Amplification Assay.
J Am Chem Soc
(2025)
147
35942
(doi: 10.1021/jacs.5c12812)